As the two aspects of GATA3 have been studied, i.e. a difference in expression between mutant and non-mutant or normal tissues and the impact of its mutations on tumor properties, it can be postulated that in agreement with previous studies, our data support the higher level of expression in tumor tissues than normal samples16,33 and the lack of importance of GATA3 somatic mutations as an independent factor in patient survival11,34. Here, GATA3 is linked to neoplasm.